Texas Yale Capital Corp. Pfizer Inc Transaction History

Texas Yale Capital Corp.

$2.09 Billion
Q2 2024

A detailed history of Texas Yale Capital Corp. transactions in Pfizer Inc stock. As of the latest transaction made, Texas Yale Capital Corp. holds 20,786 shares of PFE stock, worth $601,546. This represents 0.03% of its overall portfolio holdings.

Number of Shares

20,786

Previous 22,591 7.99%

Holding current value

$601,546

Previous $626,000 7.19%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $45,594 - $53,428	-1,805 Reduced 7.99%	20,786 $581,000
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $31,068 - $35,676	-1,200 Reduced 5.04%	22,591 $626,000
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $492,707 - $639,972	-18,856 Reduced 44.21%	23,791 $684,000
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $14,504 - $16,954	-452 Reduced 1.05%	42,647 $1.41 Million
Q2 2023 Aug 03, 2023	BUY	$36.12 - $41.79 $47,244 - $54,661	1,308 Added 3.13%	43,099 $1.58 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $8,390 - $10,922	213 Added 0.51%	41,791 $1.71 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $3,173 - $4,142	76 Added 0.18%	41,578 $2.13 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $63,452 - $77,459	-1,450 Reduced 3.38%	41,502 $1.82 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $35,362 - $41,929	-760 Reduced 1.74%	42,952 $2.25 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $34,770 - $43,084	760 Added 1.77%	43,712 $2.26 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $26,238 - $38,893	635 Added 1.5%	42,952 $2.54 Million
Q2 2021 Aug 05, 2021	SELL	$35.91 - $40.68 $3,590 - $4,068	-100 Reduced 0.24%	42,317 $1.66 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $210,987 - $237,951	-6,300 Reduced 12.93%	42,417 $1.54 Million
Q2 2020 Jul 31, 2020	SELL	$30.12 - $36.54 $288,700 - $350,235	-9,585 Reduced 16.44%	48,717 $1.59 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $622,933 - $890,036	-23,046 Reduced 28.33%	58,302 $1.9 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $32,195 - $36,538	978 Added 1.22%	81,348 $3.19 Million
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $217,747 - $282,355	-6,702 Reduced 7.7%	80,370 $2.89 Million
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $3.37 Million - $3.78 Million	-91,150 Reduced 51.14%	87,072 $3.77 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $3.3 Million - $3.63 Million	88,131 Added 97.82%	178,222 $7.57 Million
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $163,689 - $186,624	4,255 Added 4.96%	90,091 $3.93 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $82,728 - $100,344	2,400 Added 2.88%	85,836 $3.78 Million
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $41,389 - $44,125	1,255 Added 1.53%	83,436 $3.03 Million
Q1 2018 May 03, 2018	SELL	$31.91 - $37.02 $25,528 - $29,616	-800 Reduced 0.96%	82,181 $2.92 Million
Q4 2017 Feb 07, 2018	SELL	$33.26 - $35.29 $3,259 - $3,458	-98 Reduced 0.12%	82,981 $3.01 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $2.58 Million - $2.84 Million	83,079	83,079 $2.97 Million

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $162B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Yale Capital Corp., based on Form 13F filings with the SEC.

News

Stay updated on Texas Yale Capital Corp. with notifications on news.

Account

Texas Yale Capital Corp. Pfizer Inc Transaction History